Alpha-1 Antitrypsin Genotyping MSAC Submission
Information paper
Click here for Lung Foundation Australia's submission to MSAC to list Alpha-1 Antitrypsin Genotyping on the Medicare Benefits Schedule.
View more
As Australia’s leading voice on lung health issues, we work in partnership with our members, respiratory clinicians and other experts, to develop position statements, submissions, policy and budget proposals on matters affecting the lung health of Australians. Submissions and statements on the following portfolio areas can be found below.
Pharmaceutical Benefits Scheme
PBAC Consumer Comments DOS and DON’TS
This tip sheet has been written to encourage patients and health consumers to start getting ready to provide input to PBAC before a treatment is listed on the agenda.
Tip sheet for submitting consumer comments to the PBAC
This tip sheet was written by Lisa Briggs, a Stage IV Lung Cancer Patient and Advocate, whose long experience advocating for life saving drugs to be listed on the PBS means she knows the value Consumer Comments provide decisionmakers and the real impact these decisions have on people’s lives.
Tobacco Control
Submission to the Senate Inquiry on Tobacco Harm Reduction
Click here for Lung Foundation Australia's submission to the Senate Inquiry on Tobacco Harm Reduction.
Inquiry into the use and marketing of e-cigarettes
Click here for the joint submission by Lung Foundation Australia and TSANZ to the senate inquiry on the use and marketing of e-cigarettes and personal vapers.
Medical Services Advisory Committee
Occupational Lung Disease
Occupational Lung Disease Position Statement
Click here for Lung Foundation Australia's position statement on Occupational Lung Disease and how a national approach is needed to protect workers.
National Strategic Action Plan for Lung Conditions: Occupational Dust Diseases
Click here for Lung Foundation Australia's submission of the National Strategic Action plan for Occupational Dust diseases for the Dust Diseases Taskforce.